Organization | Assuta Ashdod Hospital

Assuta Ashdod Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Ashdod Israel (2001)

Organization Overview

First Clinical Trial

2010

NCT01936077

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Assuta Ashdod Hospital | Assuta Ashdod medical center | Assuta Hospital Systems | Assuta Medical Center | Elizabeth Dudnik | Head, Hand Surgery Unit, Assuta Ashdod Hospital | Uri farkash

Active Ingredients

Drugs in Phase 4 Trials (3)

lutropin alpha (luveris) (1 trial)

misoprostol (cytotec) (2 trials)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 2 Trials (3)

ad17137 (1 trial)

bendamustine (treanda) (1 trial)

obinutuzumab (gazyva) (1 trial)

Drugs in Other Trials (4)

epinephrine (levophed) (1 trial)

folic acid (1 trial)

lidocaine (xylocaine) (2 trials)

oxytocin (syntocinon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Infertility, Male (Phase 4)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 10